Cargando…
Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class
The absence of novel antibiotics for drug-resistant and biofilm-associated infections is a global public health crisis. Antimicrobial peptides explored to address this need have encountered significant development challenges associated with size, toxicity, safety profile, and pharmacokinetics. We de...
Autores principales: | Huang, David B., Brothers, Kimberly M., Mandell, Jonathan B., Taguchi, Masashi, Alexander, Peter G., Parker, Dana M., Shinabarger, Dean, Pillar, Chris, Morrissey, Ian, Hawser, Stephen, Ghahramani, Parviz, Dobbins, Despina, Pachuda, Nicholas, Montelaro, Ronald, Steckbeck, Jonathan D., Urish, Kenneth L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481017/ https://www.ncbi.nlm.nih.gov/pubmed/36112657 http://dx.doi.org/10.1371/journal.pone.0274815 |
Ejemplares similares
-
1040. Knee Explant Analysis (KnEA) Using PLG0206 in Periprosthetic Joint Infection (KnEA Study)
por: Huang, David, et al.
Publicado: (2021) -
Prospective Activity of PLG0206, an Engineered Antimicrobial Peptide, on Chronic Periprosthetic Joint Infection Total Knee Arthroplasty Components Ex Vivo: The Knee Explant Analysis (KnEA) Study
por: Huang, David, et al.
Publicado: (2021) -
1098. A Phase 1 Safety and Tolerability of Single Ascending Doses of a Novel Engineered Cationic Peptide, PLG0206, in Healthy Subjects
por: Huang, David, et al.
Publicado: (2021) -
The Engineered Antibiotic Peptide PLG0206 Eliminates Biofilms and Is a Potential Treatment for Periprosthetic Joint Infections
por: Huang, David, et al.
Publicado: (2021) -
1070. In vitro Activity of PLG0206 Against Isolates Commonly Found in Periprosthetic Joint Infections (PJI)
por: Huang, David, et al.
Publicado: (2021)